Overview

  • Product nameAnti-B3GAT3 antibodySee all B3GAT3 primary antibodies ...
  • Description
    Rabbit polyclonal to B3GAT3
  • Tested applicationsWBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Rabbit, Goat, Horse, Guinea pig, Cow, Cat, Dog, Pig
  • Immunogen

    Synthetic peptide corresponding to a region within N terminal amino acids 35-84 (PPLRAAAEQL RQKDLRISQL QAELRRPPPA PAQPPEPEAL PTIYVVTPTY) of Human B3GAT3(NP_036332).

  • Positive control
    • 721 B Cell Lysates

Properties

Applications

Our Abpromise guarantee covers the use of ab103081 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 37 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.

Target

  • FunctionGlycosaminoglycans biosynthesis. Involved in forming the linkage tetrasaccharide present in heparan sulfate and chondroitin sulfate. Transfers a glucuronic acid moiety from the uridine diphosphate-glucuronic acid (UDP-GlcUA) to the common linkage region trisaccharide Gal-beta-1,3-Gal-beta-1,4-Xyl covalently bound to a Ser residue at the glycosaminylglycan attachment site of proteoglycans. Can also play a role in the biosynthesis of l2/HNK-1 carbohydrate epitope on glycoproteins. Shows strict specificity for Gal-beta-1,3-Gal-beta-1,4-Xyl, exhibiting negligible incorporation into other galactoside substrates including Galbeta1-3Gal beta1-O-benzyl, Galbeta1-4GlcNAc and Galbeta1-4Glc.
  • Tissue specificityUbiquitous (but weakly expressed in all tissues examined).
  • PathwayProtein modification; protein glycosylation.
  • Involvement in diseaseDefects in B3GAT3 are the cause of multiple joint dislocations short stature craniofacial dysmorphism and congenital heart defects (JDSSDHD) [MIM:245600]. An autosomal recessive disease characterized by dysmorphic facies, bilateral dislocations of the elbows, hips, and knees, clubfeet, and short stature, as well as cardiovascular defects.
  • Sequence similaritiesBelongs to the glycosyltransferase 43 family.
  • Post-translational
    modifications
    N-glycosylated.
  • Cellular localizationGolgi apparatus membrane. Golgi apparatus > cis-Golgi network.
  • Information by UniProt
  • Database links
  • Alternative names
    • 3-Gal-R glucuronyltransferase antibody
    • 3-glucuronyltransferase 3 antibody
    • B3GA3_HUMAN antibody
    • B3GAT3 antibody
    • Beta 1,3 glucuronyltransferase 3 (glucuronosyltransferase I) antibody
    • Beta 1,3 glucuronyltransferase 3 antibody
    • Beta-1 antibody
    • EC 2.4.1.135 antibody
    • Galactosylgalactosylxylosylprotein 3 beta glucuronosyltransferase 3 antibody
    • Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 antibody
    • GlcAT-I antibody
    • GLCATI antibody
    • glcUAT I antibody
    • GlcUAT-I antibody
    • GlcUATI antibody
    • Glucuronosyltransferase I antibody
    • Sqv 8 like protein antibody
    • UDP GlcUA:Gal beta 1,3 Gal R glucuronyltransferase antibody
    • UDP GlcUA:Gal beta 1,3 GalR glucuronyltransferase antibody
    • UDP-GlcUA:Gal beta-1 antibody
    see all

Anti-B3GAT3 antibody images

  • Anti-B3GAT3 antibody (ab103081) at 1 µg/ml + 721 B cell lysate at 10 µg

    Predicted band size : 37 kDa

References for Anti-B3GAT3 antibody (ab103081)

ab103081 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab103081.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"